These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29248652)

  • 21. Myocardial contrast echocardiography in mice: technical and physiological aspects.
    Verkaik M; van Poelgeest EM; Kwekkeboom RFJ; Ter Wee PM; van den Brom CE; Vervloet MG; Eringa EC
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H381-H391. PubMed ID: 29101165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial perfusion imaging using contrast echocardiography.
    Pathan F; Marwick TH
    Prog Cardiovasc Dis; 2015; 57(6):632-43. PubMed ID: 25817740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal use of contrast echo in daily practice: what do we need?
    Becher H; Timperley J
    Echocardiography; 2003 Aug; 20 Suppl 1():S43-7. PubMed ID: 23573624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More may not always be better.
    Weyman AE
    JACC Cardiovasc Imaging; 2013 Jan; 6(1):13-5. PubMed ID: 23219413
    [No Abstract]   [Full Text] [Related]  

  • 25. Contrast-enhanced ultrasound using bolus injections of contrast agent for assessment of postprandial microvascular blood volume in human skeletal muscle.
    Mertz KH; Bülow J; Holm L
    Clin Physiol Funct Imaging; 2018 Sep; 38(5):864-871. PubMed ID: 29282853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats.
    Cosyns B; Droogmans S; Hernot S; Degaillier C; Garbar C; Weytjens C; Roosens B; Schoors D; Lahoutte T; Franken PR; Van Camp G
    Cardiovasc Diabetol; 2008 Sep; 7():26. PubMed ID: 18764943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.
    Porter TR; Xie F; Kilzer K
    J Am Soc Echocardiogr; 1995; 8(5 Pt 1):710-8. PubMed ID: 9417215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The feasibility and clinical utility of myocardial contrast echocardiography in clinical practice: results from the incorporation of myocardial perfusion assessment into clinical testing with stress echocardiography study.
    Shah BN; Chahal NS; Bhattacharyya S; Li W; Roussin I; Khattar RS; Senior R
    J Am Soc Echocardiogr; 2014 May; 27(5):520-30. PubMed ID: 24637056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Search of the Optimal Heart Perfusion Ultrasound Imaging Platform.
    Grishenkov D; Gonon A; Janerot-Sjoberg B
    J Ultrasound Med; 2015 Sep; 34(9):1599-605. PubMed ID: 26254153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of SonoVue in endocardial border delineation and myocardial perfusion].
    Fang LG;
    Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):824-7. PubMed ID: 15634541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of resting myocardial blood flow velocity in normal humans using real-time contrast echocardiography. A feasibility study.
    Malm S; Frigstad S; Helland F; Oye K; Slordahl S; Skjarpe T
    Cardiovasc Ultrasound; 2005 Jun; 3():16. PubMed ID: 15958173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When you have eliminated the impossible, whatever remains, however improbable, must be the truth.
    Kaul S; Wei K
    Eur J Echocardiogr; 2009 Aug; 10(6):713-5. PubMed ID: 19671627
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of cardiovascular dilution systems by contrast ultrasound.
    Mischi M; Jansen AH; Korsten HH
    Ultrasound Med Biol; 2007 Mar; 33(3):439-51. PubMed ID: 17280768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS).
    Greis C
    Clin Hemorheol Microcirc; 2011; 49(1-4):137-49. PubMed ID: 22214685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of pulmonary transit time in healthy cats by use of ultrasound contrast media "Sonovue®": feasibility, reproducibility, and values in 42 cats.
    Streitberger A; Hocke V; Modler P
    J Vet Cardiol; 2013 Sep; 15(3):181-7. PubMed ID: 23933477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bolus versus continuous infusion of microbubble contrast agent for liver ultrasound by using an automatic power injector in humans: A pilot study.
    Quaia E; Gennari AG; Angileri R; Cova MA
    J Clin Ultrasound; 2016; 44(3):136-42. PubMed ID: 26302446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress Test of Contrast-Enhanced US with Phenylephrine in a Rabbit VX2 Liver Tumor Model: Differentiating Benign Periablational Enhancement from Residual Tumor after Radiofrequency Ablation.
    Kan X; Zhang Y; Zheng C; Li L; Chen J; Wu Y; Guo T; Xiong B
    J Vasc Interv Radiol; 2016 Jul; 27(7):1077-1085.e2. PubMed ID: 27117950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oesophageal Doppler guided optimization of cardiac output does not increase visceral microvascular blood flow in healthy volunteers.
    Heinink TP; Read DJ; Mitchell WK; Bhalla A; Lund JN; Phillips BE; Williams JP
    Clin Physiol Funct Imaging; 2018 Mar; 38(2):213-219. PubMed ID: 28168868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudo-left ventricle apical hypertrophy: bedside diagnosis with SonoVue contrast.
    Comella A; Magnacca M
    Echocardiography; 2004 Aug; 21(6):563-4. PubMed ID: 15298696
    [No Abstract]   [Full Text] [Related]  

  • 40. Design of an ultrasound contrast agent for myocardial perfusion.
    Schneider M
    Echocardiography; 2000 Aug; 17(6 Pt 2):S11-6. PubMed ID: 11058234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.